Nuzenio

Drma

Drma news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 10 latest news signals 7 publisher sources 100/100 entity strength

Latest news

DRMA 8-K & SEC Filings - Yahoo FinanceYahoo Finance · Sat, 08 Aug 2026 09:22:12 GMTDermata Therapeutics Inc (NASDAQ: DRMA) Share Price, DRMA Stock News, DRMA Share Price & Updates - KalkineKalkine · Fri, 07 Aug 2026 20:00:00 GMTDermata's planned $178 skincare set includes four weekly treatments - Stock TitanStock Titan · Wed, 05 Aug 2026 12:30:00 GMTDermata Therapeutics Announces Commercial Launch Date for Tome(TM) Foundational Treatment - The Globe and MailThe Globe and Mail · Wed, 05 Aug 2026 12:30:00 GMTDRMA Q1 2026 Earnings: Narrower-than-Expected Loss Delivers 11.21% EPS Surprise as Pipeline Takes Center Stage - Earnings Cycle Report - dars.gov.etdars.gov.et · Sun, 02 Aug 2026 13:31:41 GMTDRMA Q1 2026 Earnings: Narrower Loss of $0.48 per Share Beats Estimates as Clinical-Stage Biotech Remains Pre-Revenue - Guidance vs Actual - dars.gov.etdars.gov.et · Fri, 31 Jul 2026 07:00:00 GMTDermata Therapeutics, Inc. Revenue Breakdown – NASDAQ:DRMA - TradingViewTradingView · Thu, 30 Jul 2026 08:02:46 GMTDermata Therapeutics Inc (DRMA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKeyTradingKey · Mon, 27 Jul 2026 23:25:53 GMT

Timeline

Sat, 08 Aug 2026 09:22:12 GMTDRMA 8-K & SEC Filings - Yahoo Finance
Fri, 07 Aug 2026 20:00:00 GMTDermata Therapeutics Inc (NASDAQ: DRMA) Share Price, DRMA Stock News, DRMA Share Price & Updates - Kalkine
Wed, 05 Aug 2026 12:30:00 GMTDermata's planned $178 skincare set includes four weekly treatments - Stock Titan
Wed, 05 Aug 2026 12:30:00 GMTDermata Therapeutics Announces Commercial Launch Date for Tome(TM) Foundational Treatment - The Globe and Mail
Sun, 02 Aug 2026 13:31:41 GMTDRMA Q1 2026 Earnings: Narrower-than-Expected Loss Delivers 11.21% EPS Surprise as Pipeline Takes Center Stage - Earnings Cycle Report - dars.gov.et
Fri, 31 Jul 2026 07:00:00 GMTDRMA Q1 2026 Earnings: Narrower Loss of $0.48 per Share Beats Estimates as Clinical-Stage Biotech Remains Pre-Revenue - Guidance vs Actual - dars.gov.et

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Drma.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

7 distinct publisher/source names are currently connected to this entity page.